In late-stage cancer cells, a higher expression of NrF2, HIF-1α, and UPR promotes a marked upregulation of the aforementioned intracellular antioxidative defense mechanisms and systems promoting the maintenance of redox homeostasis, which makes cancer cells insensitive against oxidative stress and additional stress induced by chemo- and radiotherapy. The gene discussed is NFE2L2; the disease is cancer.